We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Implant Aids Gastroparesis Patients

By HospiMedica staff writers
Posted on 03 Jan 2001
A neurostimulator implant that delivers mild electrical pulses to nerves in the stomach has been shown to reduce the symptoms of nausea and vomiting and improve the quality of life for patients who suffer from severe gastroparesis and have not responded to standard medication.

In clinical trials, 93% of patients with the implant experienced a greater-than-50% reduction of vomiting episodes, while 66% with the implant experienced a greater-than-80% reduction. More...
The therapy, called Enterra Therapy, is the product of Medtronic, Inc. (Minneapolis, MN, USA). The U.S. Food and Drug Administration (FDA) granted the company a humanitarian device exemption for the system, a special regulatory clearance intended to benefit patients by treating or diagnosing a rare disease or condition.

Gastroparesis is characterized by abnormal neuromuscular activity of the stomach that slows the movement of food through the stomach. Some patients with the disorder experience chronic nausea and vomiting that can lead to hydration and malnutrition. An estimated 25% of diabetics have or will develop gastroparesis.



Related Links:
Enterra Therapy

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.